|
|
 |
Bio Technology 
Events |
|
| | BIO-Europe 2010—16th Annual International Partnering Conference |
| | Nov 15, 2010 - Nov 17, 2010 |
| | International Congress Centre Munich (ICM) Munich Germany |
| | Building value through partnerships
BIO-Europe is the preeminent partnering conference for the life sciences. BIO-Europe brings together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships.
The BIO-Europe 2010 partnering event is expected to draw over 2,500 industry attendees for three days of high level networking, representing upwards of 1,400 companies from 50 countries.
Partnering at BIO-Europe is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners and pre-arrange private one-to-one meetings with dozens of company targets. The system—industry-specific, web-based and interactive—is uniquely suited for the needs of life science companies.
BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Industry Organization (BIO).
For more information and online registration please visit our conference website at www.ebdgroup.com/bioeurope
Contact: Thomas Voigt, tvoigt@ebdgroup.com |
|
|
| | Generics & Biosimilars Asia 2011 |
| | Mar 3, 2011 - Apr 3, 2011 |
| | Amara Hotel, Singapore |
| | Conference only price: SGD 3299
Event information:
The global generics market is forecast to be valued at $183.2 billion by 2014, with Asia Pacific accounting for 36.2% of the global generics market. (companiesandmarkets.com)
With strong demand for affordable healthcare throughout Asia governments are favoring the production and prescription of generics and biosimilars. The Generics & Biosimilars Asia 2011 conference is set to address many of the pressing issues faced by both innovator and generic drug companies. Attendees will be able to network and learn from peers facing similar challenges in market access, drug pricing and reimbursement in the evolving pharmaceutical industry in Asia. Addressing the multi-faceted challenges of the off-patent drug industry to ensure company profitability, consumer safety and realizing the demand for affordable healthcare. |
|
|
|
|
|
|
|
|
|
|
